Study analysis · Frontiers in Physiology · 2026
Stopping exercise doesn't erase all your progress—but the benefits fade in surprising ways, and some may be illusions.
A review of 86 studies found that after you stop exercising, some benefits like weight and fitness stick around for months, but blood sugar and cholesterol improvements disappear within 2 months.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This is a big review of many randomized trials, which is the best kind of medical evidence. It suggests that after people stop exercising, some health benefits may stick around for a while, but not all benefits last, and we can't be sure exactly why or for how long. So it's good evidence that benefits don't vanish instantly, but not proof that stopping exercise is harmless.
What’s the bottom line?
A big review of 86 studies looked at what happens to your body when you stop exercising after a training program. They found that some benefits stick around for a while, but others fade quickly.
How strong is this study?
The review was done carefully, but most of the original studies had some problems, like unclear randomization or missing details. That means we can trust the general pattern, but we should be careful about specific numbers and long-term claims. It's like a well-done class project using many imperfect sources.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
38 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample size (n=5670)+20/20
- Follow-up+10/10
100 / 100
100 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 558 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
This design can establish causation. Although this is a systematic review and meta-analysis of randomized controlled trials (Level 1a), causal inference is limited by several factors: the detraining phase itself is not randomized, many analyses compare baseline to post-detraining values rather than between randomized groups, 85% of included trials had 'some concerns' and 10% had 'high risk' of bias, heterogeneity was substantial, and GRADE certainty was only moderate for key outcomes and low/very low for some long-term outcomes. Therefore, causal claims should be tempered and reserved for outcomes with stronger certainty.
COI Unknown
Could not determine conflict of interest status
No conflict of interest or funding statement is present in the provided text; therefore conflicts of interest and funding sources cannot be assessed.
The provided text is truncated and lacks the declarations, funding, and conflict of interest sections typically found at the end of articles. No author affiliations or industry ties are visible.
Key takeaways
- 01
After stopping exercise, people weighed about 1.1 to 2.1 kg less than before they started, and their waist was about 1.4 to 2.2 cm smaller, even after more than 6 months.
- 02
Their fitness (VO2max) stayed higher.
- 03
But blood sugar and cholesterol benefits mostly disappeared within 2 months.
- 04
The weight and waist reductions are modest and may not be clinically meaningful.
- 05
The weight loss of 1-2 kg is less than the 5% of body weight usually needed for health benefits, and the waist reduction of 1-2 cm is small.
- 06
So while some benefits persist after stopping exercise, they are modest and may not provide major health advantages on their own.
Surprising findings
- Fasting insulin showed a paradoxical improvement after detraining when it wasn't improved after training.It contradicts the expectation that stopping exercise worsens insulin sensitivity.
- VO2max remained higher even after >6 months of detraining, unlike in athletes.Athletes lose fitness rapidly, but this review found durable improvements in general populations.
- Body mass and waist circumference remained lower, but muscle mass and lean body mass reverted to baseline within 2 months.Weight stayed lower, but body composition worsened, suggesting fat may have increased while muscle decreased.
Practical takeaways
If you must take a break from exercise, don't stress—some benefits like fitness and blood pressure may persist for months.
Metabolic benefits fade within 2 months, and muscle mass declines, so try to maintain some activity.
moderate confidenceDuring breaks, focus on preserving muscle mass with minimal resistance training or high-protein diet.
The study didn't test interventions to preserve muscle during detraining.
low confidenceEven small reductions in blood pressure from exercise can have public health benefits, so regular exercise is still worthwhile.
Individual clinical relevance is uncertain.
moderate confidenceWhy this study matters
Weight and Waist Stay Lower, But Not Enough to Matter
After stopping exercise, people weighed 1.12–2.09 kg less and had waists 1.43–2.17 cm smaller for up to 6 months. However, these reductions are below clinically meaningful thresholds (5% body mass, 2 cm waist).
People often think any weight loss is meaningful, but the study shows these residual benefits may not translate to real health improvements.
Fitness Sticks Around Longer Than You Think
VO2max remained significantly higher even after >6 months of detraining (SMD 0.29–0.62). This contrasts with athletes, who lose fitness quickly.
This suggests that for everyday people, fitness gains are more durable than expected.
Blood Pressure Benefits Persist, But Are Small
Systolic blood pressure remained 2.69 mmHg lower after >6 months of detraining. While modest, even small reductions can have public health benefits.
Small changes can matter at a population level, but individuals may not notice.
Metabolic Benefits Vanish Quickly
Glucose and lipid markers largely reverted within 2 months of stopping exercise. Insulin sensitivity may decline within days.
This highlights the importance of continuous exercise for metabolic health.
The Strange Case of Fasting Insulin
Fasting insulin was not significantly reduced after training, but became significantly reduced after detraining (SMD −0.41). The authors call this a likely artifact.
It's a counterintuitive finding that shows how statistics can mislead.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
A big review of 86 studies looked at what happens to your body when you stop exercising after a training program. They found that some benefits stick around for a while, but others fade quickly.
Research results
After stopping exercise, people weighed about 1.1 to 2.1 kg less than before they started, and their waist was about 1.4 to 2.2 cm smaller, even after more than 6 months. Their fitness (VO2max) stayed higher. But blood sugar and cholesterol benefits mostly disappeared within 2 months. The weight and waist reductions are modest and may not be clinically meaningful.
What this means - more context
The weight loss of 1-2 kg is less than the 5% of body weight usually needed for health benefits, and the waist reduction of 1-2 cm is small. So while some benefits persist after stopping exercise, they are modest and may not provide major health advantages on their own.
To evaluate the effect of detraining after exercise on body composition and cardiometabolic health through a systematic review and meta-analysis of randomized controlled trials.
In 86 RCTs (n=5,670), exercise-induced improvements in body composition and cardiometabolic health did not immediately return to baseline after detraining. Residual benefits were outcome-specific and time-dependent: body mass remained 1.12–2.09 kg lower (absolute) and waist circumference 1.43–2.17 cm lower (absolute) for >6 months, but these are below clinically meaningful thresholds (≥5% body mass, ≥2 cm waist). VO2max remained higher (standardized mean difference 0.29–0.62), and systolic blood pressure remained 2.69 mmHg lower (absolute). However, glucose and lipid metabolic markers largely reverted within 2 months. Certainty of evidence was moderate for most outcomes, but low/very low for long-term effects due to risk of bias and imprecision.
Methods Used
Systematic review and meta-analysis of RCTs with an exercise phase followed by detraining. Searched PubMed, Web of Science, Embase, SPORTDiscus, MEDLINE, and CINAHL. Included 86 RCTs (n=5,670). Risk of bias assessed with Cochrane RoB2; certainty of evidence with GRADE. Random-effects meta-analyses with subgroup analyses by detraining duration (short-term ≤2 months, medium-term 2–6 months, long-term >6 months).
Main Finding
After detraining, body mass remained 1.12–2.09 kg lower (absolute) and waist circumference 1.43–2.17 cm lower (absolute) than baseline for up to >6 months, but these reductions are modest and generally below clinically meaningful thresholds. VO2max remained significantly higher (standardized mean difference 0.29–0.62). Systolic blood pressure remained 2.69 mmHg lower (absolute). Glucose and lipid metabolic markers, muscle mass, and lean body mass largely reverted within 2 months. The authors conclude that residual benefits are outcome-specific and time-dependent, but caution that findings are suggestive due to risk of bias and low certainty for long-term outcomes.
Confidence Level
GRADE assessment: moderate certainty for most key outcomes (body mass, BMI, SBP, DBP, VO2peak); low or very low certainty for long-term residual effects due to risk of bias, imprecision, and small sample sizes. 85% of included studies had some concerns and 10% high risk of bias. Publication bias detected for some outcomes (body mass short-term, BMI short-term, WC long-term, RHR short-term).
Study Flags
Red Flags
- •High heterogeneity across studies
- •Most studies had some concerns or high risk of bias
- •Publication bias detected for some outcomes
- •Lack of monitoring of lifestyle changes during detraining
- •Many subgroup analyses based on few studies
Surprising Findings
Fasting insulin showed a paradoxical improvement after detraining when it wasn't improved after training.
It contradicts the expectation that stopping exercise worsens insulin sensitivity.
Practical Takeaways
If you must take a break from exercise, don't stress—some benefits like fitness and blood pressure may persist for months.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 558 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
Human Meta-Analysis
Subject
Moderate probability
on the GRADE evidence scale
This is a big review of many randomized trials, which is the best kind of medical evidence. It suggests that after people stop exercising, some health benefits may stick around for a while, but not all benefits last, and we can't be sure exactly why or for how long. So it's good evidence that benefits don't vanish instantly, but not proof that stopping exercise is harmless.
Strengths
- Systematic review and meta-analysis of 86 randomized controlled trials with 5,670 participants.
- Comprehensive search across six major databases (PubMed, Web of Science, Embase, SPORTDiscus, MEDLINE, CINAHL).
- Pre-registered protocol on PROSPERO (CRD420251149494).
Weaknesses
- Only 5% of included trials had low risk of bias; 85% had some concerns and 10% had high risk.
- Randomization process and selection of reported results were frequent sources of bias, with about 65% lacking allocation concealment details or pre-registered protocols.
- Blinding of participants and personnel was largely infeasible, though objective outcomes mitigate this.
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
A big review of 86 studies looked at what happens to your body when you stop exercising after a training program. They found that some benefits stick around for a while, but others fade quickly.
Research results
After stopping exercise, people weighed about 1.1 to 2.1 kg less than before they started, and their waist was about 1.4 to 2.2 cm smaller, even after more than 6 months. Their fitness (VO2max) stayed higher. But blood sugar and cholesterol benefits mostly disappeared within 2 months. The weight and waist reductions are modest and may not be clinically meaningful.
What this means - more context
The weight loss of 1-2 kg is less than the 5% of body weight usually needed for health benefits, and the waist reduction of 1-2 cm is small. So while some benefits persist after stopping exercise, they are modest and may not provide major health advantages on their own.
To evaluate the effect of detraining after exercise on body composition and cardiometabolic health through a systematic review and meta-analysis of randomized controlled trials.
In 86 RCTs (n=5,670), exercise-induced improvements in body composition and cardiometabolic health did not immediately return to baseline after detraining. Residual benefits were outcome-specific and time-dependent: body mass remained 1.12–2.09 kg lower (absolute) and waist circumference 1.43–2.17 cm lower (absolute) for >6 months, but these are below clinically meaningful thresholds (≥5% body mass, ≥2 cm waist). VO2max remained higher (standardized mean difference 0.29–0.62), and systolic blood pressure remained 2.69 mmHg lower (absolute). However, glucose and lipid metabolic markers largely reverted within 2 months. Certainty of evidence was moderate for most outcomes, but low/very low for long-term effects due to risk of bias and imprecision.
Methods Used
Systematic review and meta-analysis of RCTs with an exercise phase followed by detraining. Searched PubMed, Web of Science, Embase, SPORTDiscus, MEDLINE, and CINAHL. Included 86 RCTs (n=5,670). Risk of bias assessed with Cochrane RoB2; certainty of evidence with GRADE. Random-effects meta-analyses with subgroup analyses by detraining duration (short-term ≤2 months, medium-term 2–6 months, long-term >6 months).
Main Finding
After detraining, body mass remained 1.12–2.09 kg lower (absolute) and waist circumference 1.43–2.17 cm lower (absolute) than baseline for up to >6 months, but these reductions are modest and generally below clinically meaningful thresholds. VO2max remained significantly higher (standardized mean difference 0.29–0.62). Systolic blood pressure remained 2.69 mmHg lower (absolute). Glucose and lipid metabolic markers, muscle mass, and lean body mass largely reverted within 2 months. The authors conclude that residual benefits are outcome-specific and time-dependent, but caution that findings are suggestive due to risk of bias and low certainty for long-term outcomes.
Confidence Level
GRADE assessment: moderate certainty for most key outcomes (body mass, BMI, SBP, DBP, VO2peak); low or very low certainty for long-term residual effects due to risk of bias, imprecision, and small sample sizes. 85% of included studies had some concerns and 10% high risk of bias. Publication bias detected for some outcomes (body mass short-term, BMI short-term, WC long-term, RHR short-term).
Study Flags
Red Flags
- •High heterogeneity across studies
- •Most studies had some concerns or high risk of bias
- •Publication bias detected for some outcomes
- •Lack of monitoring of lifestyle changes during detraining
- •Many subgroup analyses based on few studies
Surprising Findings
Fasting insulin showed a paradoxical improvement after detraining when it wasn't improved after training.
It contradicts the expectation that stopping exercise worsens insulin sensitivity.
Practical Takeaways
If you must take a break from exercise, don't stress—some benefits like fitness and blood pressure may persist for months.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 558 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
Human Meta-Analysis
Subject
Moderate probability
on the GRADE evidence scale
This is a big review of many randomized trials, which is the best kind of medical evidence. It suggests that after people stop exercising, some health benefits may stick around for a while, but not all benefits last, and we can't be sure exactly why or for how long. So it's good evidence that benefits don't vanish instantly, but not proof that stopping exercise is harmless.
Strengths
- Systematic review and meta-analysis of 86 randomized controlled trials with 5,670 participants.
- Comprehensive search across six major databases (PubMed, Web of Science, Embase, SPORTDiscus, MEDLINE, CINAHL).
- Pre-registered protocol on PROSPERO (CRD420251149494).
Weaknesses
- Only 5% of included trials had low risk of bias; 85% had some concerns and 10% had high risk.
- Randomization process and selection of reported results were frequent sources of bias, with about 65% lacking allocation concealment details or pre-registered protocols.
- Blinding of participants and personnel was largely infeasible, though objective outcomes mitigate this.
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The review was done carefully, but most of the original studies had some problems, like unclear randomization or missing details. That means we can trust the general pattern, but we should be careful about specific numbers and long-term claims. It's like a well-done class project using many imperfect sources.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
38 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample size (n=5670)+20/20
- Follow-up+10/10
100 / 100
100 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 558 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
This design can establish causation. Although this is a systematic review and meta-analysis of randomized controlled trials (Level 1a), causal inference is limited by several factors: the detraining phase itself is not randomized, many analyses compare baseline to post-detraining values rather than between randomized groups, 85% of included trials had 'some concerns' and 10% had 'high risk' of bias, heterogeneity was substantial, and GRADE certainty was only moderate for key outcomes and low/very low for some long-term outcomes. Therefore, causal claims should be tempered and reserved for outcomes with stronger certainty.
COI Unknown
Could not determine conflict of interest status
No conflict of interest or funding statement is present in the provided text; therefore conflicts of interest and funding sources cannot be assessed.
The provided text is truncated and lacks the declarations, funding, and conflict of interest sections typically found at the end of articles. No author affiliations or industry ties are visible.
Standing
The people behind it
The researchers who wrote the study this analysis is built on.
Authored by
4 researchersIf this is your work, this is how we attribute it on Fit Body Science. Hao Zhang is listed as the lead author.